Simplifying Global Compliance
Proposed Combo Products Rule Underestimates Cost of GMPs
Devices & Diagnostics Letter
The FDA’s proposed rule on good manufacturing practices (GMPs) for combination products grossly underestimates the burden of applying certain cGMP requirements to device-drug combinations, a device company says.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing